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Background: Severe malaria remains a major cause of pediatric hospital admission across Africa. Invasive bacterial
infection (IBI) is a recognized complication of Plasmodium falciparum malaria, resulting in a substantially worse
outcome. Whether a biological relationship exists between malaria infection and IBI susceptibility remains unclear.
We, therefore, examined the extent, nature and evidence of this association.
Methods: We conducted a systematic search in August 2012 of three major scientific databases, PubMed, Embase
and Africa Wide Information, for articles describing bacterial infection among children with P. falciparum malaria
using the search string ‘(malaria OR plasmodium) AND (bacteria OR bacterial OR bacteremia OR bacteraemia OR
sepsis OR septicaemia OR septicemia).’ Eligiblity criteria also included studies of children hospitalized with malaria or
outpatient attendances in sub-Saharan Africa.
Results: A total of 25 studies across 11 African countries fulfilled our criteria. They comprised twenty cohort
analyses, two randomized controlled trials and three prospective epidemiological studies. In the meta-analysis of
7,208 children with severe malaria the mean prevalence of IBI was 6.4% (95% confidence interval (CI) 5.81 to 6.98%).
In a further meta-analysis of 20,889 children hospitalised with all-severity malaria and 27,641 children with
non-malarial febrile illness the mean prevalence of IBI was 5.58 (95% CI 5.5 to 5.66%) in children with malaria and
7.77% (95% CI 7.72 to 7.83%) in non-malaria illness. Ten studies reported mortality stratified by IBI. Case fatality was
higher at 81 of 336, 24.1% (95% CI 18.9 to 29.4) in children with malaria/IBI co-infection compared to 585 of 5,760,
10.2% (95% CI 9.3 to 10.98) with malaria alone. Enteric gram-negative organisms were over-represented in malaria
cases, non-typhoidal Salmonellae being the most commonest isolate. There was weak evidence indicating IBI was
more common in the severe anemia manifestation of severe malaria.
Conclusions: The accumulated evidence suggests that children with recent or acute malaria are at risk of bacterial
infection, which results in an increased risk of mortality. Characterising the exact nature of this association is
challenging due to the paucity of appropriate severity-matched controls and the heterogeneous data. Further
research to define those at greatest risk is necessary to target antimicrobial treatment.
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Malaria remains a leading cause of childhood morbidity
and mortality worldwide, accounting for 7% of deaths in
children younger than five years of age [1]. In the past
few years two of the largest clinical trials ever conducted
in African children with severe malaria (SM) have con-
cluded, both holding major implications for treatment
guidelines [2,3]. With the introduction of artesunate in
sub-Saharan Africa (sSA), baseline mortality in children
with SM will at best be between 6% to 8.5% but likely to
be substantially higher outside the framework of Good
Clinical Practice-run trials. Understanding the key corre-
lates of poor outcome may identify future targets for add-
itional definitive or adjunctive treatments.
Over time there has been a piecemeal accumulation of
data indicating that children with Plasmodium falciparum
malaria are at risk of invasive bacterial infection (IBI).
Blood stream infection, largely secondary to enteric Gram-
negative organisms (EGNOs), with a predominance of
non-typhoidal salmonella (NTS) species, has been widely
reported as a complication of severe malaria. However, it
remains uncertain whether malaria infection is a risk
factor for invasive bacterial disease since the majority
of children in malaria-endemic Africa are frequently
infected by P. falciparum throughout childhood and
only a minority will develop severe disease. A sub-analysis
within a comprehensive systematic review of blood stream
infections in Africa indicated that 6.5% of 11,814 mal-
aria infections had concomitant bacteremia [4]. Which
children are at greatest risk of developing dual infection
and whether this extends across the clinical spectrum
(asymptomatic, mild and severe) remains unclear.
This is important for two reasons. Firstly, concomitant
IBI in children hospitalized with evidence of recent or
intercurrent malaria, with or without severe manifestations,
results in a significantly worse outcome. In one epidemio-
logical study an estimated one third of all SM deaths were
attributable to bacteremia [5]. Secondly, it has implica-
tions when considering revisions of current management
guidelines to include routine provision of antibiotics to
all children with malaria. Routine antibiotics, along with
anti-malarials, are currently recommended for children
with SM [6]. However, malaria remains a very common
cause of pediatric admission and the indiscriminate use
of antibiotics would be both financially costly and could
perpetuate the rise of antibiotic resistance. Thus, there
remains a need for clarity on whether children with
malaria are more susceptible to a bacterial infection and
its precise nature in order to tailor antimicrobial man-
agement. In this systematic review we bring together
the current breadth of published data on the prevalence
of IBI among African children with malaria.
We reviewed published observational and epidemiological
data in order to establish whether there was evidence of anassociation between malaria and IBI. We sought to deter-
mine the prevalence of co-infection in children with malaria
infection, the risk factors for co-infection and the mortality
effect in African children, drawing on this knowledge to
consider the implications for future treatment guidance.
Methods
Studies were eligible for inclusion in the review if they
were conducted among children with malaria, who had
blood cultures taken and were admitted to hospitals or
outpatient clinics in sSA. Although we restricted our review
to studies reporting bacteremia, we did not exclude studies
describing other bacterial co-infection, such as urinary tract
infection or meningitis.
We performed a systematic search for articles describing
bacterial infection among children with P. falciparum mal-
aria. Search terms used were ‘(malaria OR plasmodium)’
AND ‘(bacteria OR bacterial OR bacteremia OR bacter-
aemia OR sepsis OR septicaemia OR septicemia)’ in three
major scientific databases, PubMed, Embase and Africa
Wide Information (AWI). The Internet search was carried
out on 13 and 14 August 2012. Searches of PubMed and
Embase were limited to humans while AWI was lim-
ited to humans and scholarly (peer reviewed) journals.
Abstracts and titles from all years were compiled in
Endnote (Thomson Reuters) and screened, after the re-
moval of duplicates. Prospective studies were required
to recruit children systematically or consecutively and
to evaluate all cases. Our review was restricted to arti-
cles either written in English or translated into English.
Unpublished data were not included. The protocol and
review are not registered.
Eligible publications were retrieved in full text if
available online or from academic libraries. Both pro-
spective and retrospective case series of children with
malaria undergoing blood culture were subdivided ac-
cording to principal inclusion criteria (SM, all malaria
or non-severe malaria). Studies principally reporting
epidemiological associations were tabled separately.
The definitions of SM varied widely. In order to facili-
tate agreement between the reviewers for study inclu-
sion we used the following criteria for assessment of
the quality of studies reporting on severe malaria (SM):
1) criteria for SM well-defined; 2) bacterial species de-
fined or quality assurance verified that contaminants
were excluded; 3) mortality data for ‘high risk’ SM cohort
at least 7.4% (the lowest 95% confidence for artesunate
arm of the AQUAMAT multicountry trial [2]; the overall
mortality in this arm was 8.5% (7.4% to 9.5%)) [2]. These
were ranked as low, moderate and high (1, 2 and 3) ac-
cording to the number of criteria met. We reviewed the
reference lists from articles rated ‘high quality’ to identify
additional secondary articles not found during the initial
online search.
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studies during abstract review if they did not include a
cohort of patients with a confirmed diagnosis of malaria,
case reports, review articles or behavioral studies. During
full text review, we excluded studies if they were conducted
outside of sSA, did not report any microbiological data
or featured predominantly adults. Studies reporting a
mixed adult child population were only included if the
data for children could be readily separated. Studies in
which relevant data could not be extracted or where inclu-
sion criteria failed to represent a population of children
with malaria, were also excluded. For study sites generating
several papers from the same study cohort, we included
only the most appropriate study unless time periods varied.
Data on neonates were excluded since neonates represent a
group largely unaffected by malaria but with an unrelated,
distinct vulnerability for IBI. We did not actively con-
sult with specialists in the field to discuss or review.
For each study we worked out case fractions for mal-
aria IBI co-infection as ‘number of children with malaria
AND IBI’ (numerator) divided by ‘number of children with
malaria’ (denominator). We used the Q test, as a measure
of heterogeneity among studies, calculated as the weighted
sum of squared differences between individual study effects
and the pooled effect across studies. I2 was calculated to
quantify heterogeneity (between-studies variability) [7].
Since the definitions for SM vary from study to study,
we also compared the study inclusion criteria for SM
cases with the WHO definition of SM [8].
Results
Our search of the published literature yielded 10,200 articles
and 7,897 unique articles following removal of duplicates.
After reviewing the abstracts 72 full text reports were iden-
tified for closer evaluation, which were reduced to 21 stud-
ies after applying the exclusion criteria (Figure 1).
We excluded 15 studies since they described specific
populations not primarily defined by malaria status. Studies
alluding to an association between malaria and IBI but with
incomplete information or unsuitable study design were
tabulated separately (Additional file 1: Table S2). Only
four studies were excluded due to location outside of
sSSA, highlighting the dearth of data from other re-
gions. Three of these studies reported predominantly
data from adults [9-11]. A study of 340 children with se-
vere malaria in Papua New Guinea recorded two cases
of malaria with concomitant infection (invasive candida
and Klebsiella Pneumoniae); however, not all children
had blood cultures taken [12]. Other reasons for exclu-
sion are detailed in Additional file 1: Table S1.
A further four papers were found from scanning refer-
ence lists of selected articles, leaving 25 studies from a
total of 11 sSA countries. They comprised twenty cohort
analyses (including inpatient and outpatients studies),two randomized controlled trials and three epidemio-
logical studies, summarized in Tables 1 and 2 according
to study type and clinical severity.
Evidence of IBD co-infection in malaria
Table 1 summarizes the data from 22 studies reporting
the incidence of bacteremia in children with malaria in
sSA, subdivided according to malaria case definition
(severe malaria, all-severity malaria and non-severe).
Information on location, study period, hospital type,
case fraction of malaria-IBI, predominant organisms
causing IBI and mortality data is included. In total, 21
studies described hospitalized inpatients and 14 were
conducted prospectively.
Severe malaria
The first section of Table 1 summarizes the details of the
10 studies reporting data on children admitted with severe
malaria over the period 1992 to 2010 from 15 centers in 11
sSA countries. In total, these involved 7,208 children, in-
cluding 461 with concomitant IBI, mean case fraction 6.4%
(95% confidence interval (CI) 5.81 to 6.98%). Eight studies
involved children with all types of severe malaria, including
one randomized controlled trial, whereas two only included
children with cerebral malaria. With one exception [13], all
studies used a positive blood slide as part of their severe
malaria definition. The data from these 10 studies are sum-
marized in Table 3, together with an assessment of the
study quality. The case fraction with IBI varied according
to study quality from 6.01% (95% CI 5.27 to 6.74) in the
highest ranked studies including 256 bacteremias in 4,261
cases to 8.2% (95% CI 5.92 to 24.26%) involving 50 bacter-
emias in 610 children in the lowest ranked studies (Table 3).
The Q test and I2 statistic were 40.1 and 77.5, respectively,
indicating substantial heterogeneity and between-study
variability; thus, a formal meta-analysis was not performed.
Of note, other studies, not included in this table, described
other bacterial infections (pneumonia [14,15], meningitis
[16-18] and urinary tract infections [19-21]) complicating
malaria. Only three studies included information on a
non-malaria comparator group [22-24].
All severity malaria: hospital studies
The second section of Table 1 summarizes data from an-
other 10 studies that were largely prospective studies of fe-
brile children admitted to health facilities. In total, these 10
studies included 20,889 children with malaria and 27,641
children with non-malarial febrile illness as a comparator
group (eight studies only). Bacterial infection was present
in 1,166 children with malaria, 5.58% (95% CI 5.50 to 5.66),
and 2,148 children without malaria, mean case fraction
7.77%, (95% CI 7.72 to 7.83%). In six out of eight studies
with comparator groups, bacteremia was more common in
the non-malarial febrile children (Table 4). Based on the
10,200 articles yielded from initial search 
5620 - Pubmed
2858 - Embase
1722  - Africa Wide Information
2303 excluded after removal of duplicates
7815 excluded after scanning titles/abstracts     
14 - Predominantly adults 
8 - Microbiological data incomplete or not reported  
7 - Unable to extract sufficient data  
6 - Cohort described elsewhere in another paper  
4 - Not sub Saharan Africa  
25 articles included in final analysis
4 articles included after scanning reference 
lists from selected articles
47 excluded after review of full article (see Additional File A2) 
16 - Cohort not representative of children with malaria 
Figure 1 PRISMA flow diagram. Legend: nts, non-typhoidal salmonellae; str.pn, Streptococcus Pneumoniae; h. inf, Haemophilus Influenzae;
s. typh, Salmonellae Typhi; gm neg, Gram negative organisms; gm pos, Gram positive organisms.
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20,323 children hospitalized with malaria (n = 1,102; 5.4%;
(95% CI 5.3 to 5.5) and 27,641 children with non-malarial
febrile illness (n = 2,148; 7.77%) (Table 4), we derived a
malaria attribution case fraction (MAF), indicating that
children with malaria were less likely to have IBI than chil-
dren with other causes of febrile illness (MAF = −2.35%).
Two studies reported a higher case faction of malaria co-
infection than non-malarial febrile illness in the Democratic
Republic of the Congo (DRC) [25] (24.7% versus 13.0%)
and in the Gambia (10.1% versus 1.97%) [26]. The latter
study also included recent cases of malaria (defined as
the presence of P. falciparum gametocytes and/or pig-
ment on a blood film). However, interpreting data from
these studies, which used hospitalized children with
non-malarial febrile illness as a comparator group, one
must consider the possibility of selection bias. If the
threshold for admission in children with confirmed
malaria is lower, whereas children with a non-malarial
febrile illness require one or more manifestations of severedisease in order to be hospitalized, the groups may no
longer be appropriately matched for comparison.
Non-severe malaria: outpatient studies
Two prospective studies (final section Table 1) describing
children with non-severe malaria and concomitant IBI who
did not require admission [27,28] reported vastly different
case fractions of IBI (16 of 47 (34%) versus 7 of 480 (1.5%),
respectively. The scarcity of this type of study in describing
IBI reflects the absence of blood culture data in children in
the outpatient setting.
Other studies
Several case series, reporting prevalence and etiology
of community-acquired bacteremias, have also inferred
a relationship between malaria and IBI by reporting the in-
cidence of malaria parasitemia in children with bacteremia
(see Additional file 1: Table S1). In a Rwandan study,
27% of children with community-acquired bacteremia
had concomitant parasitemia [29]. Malawian children
Table 1 Summary of 22 observational studies recording invasive bacterial infection (IBI) in children with Plasmodium falciparum malaria in sSA
Author Location Study period Study type;
primary
inclusion criteria.
Hospital type
Age
range
Number
in study
Cases with
malaria
Number
Cases
with IBI
number
Case fraction
with malaria
IBI co infection
Predominant
organisms IBI
Co-infection
Comments or associations
n/N (%)
SEVERE MALARIA
Angyo [13] Jos, Nigeria Aug 92 – Oct 93 PCS; 1 m-14y 501 501 35 7.0% SPN 34.3% SM definition included slide negative
cases (n = 214). SM mortality = 3.2%.
Severe malaria.
Urban TH
S. aureus 20%
Salm spp 14.3%
Bassat [23] Manhica,
Mozambique
Jun 03 – May 07 RCS; 0-5ya 1,780 1,404 with
BC data
76 5.4% All EGN 36.8%
NTS 15.8%
High mortality SMA and IBI (31%).
Severe malaria.
Rural DH
SPN 26.3%. Valid BC data excludes contaminants
S. aureus 17%,
Berkley [36] Kilifi, Kenya Apr 93 – May 96 RCS NR 783 643 with
BC data
42 6.5% SPN 30% Bacteremia less prevalent in >30 m (2.5%).
S. aureus 16%
Severe malaria.
Rural DH
NTS 14%
Berkley [24] Kilifi, Kenya Aug 98 – Jul 02 PCS >60d 3,068 2,048 127 6.2% EGN at high
parasite counts
>50,000
Mortality strongly correlated with IBI
(but not with SPN and HIb).
Severe malaria.
Rural DH
Case fatality inversely related to parasitemia.
Bronzan [38] Blantyre,
Malawi
1996 - 2005 PCS; >6 m 1,388 1,388 64 4.6% NTS 58% Invasive NTS assoc with severe anemia
(73% of NTS cases). Not associated with
mortality.(Rainy seasons) Severe malaria.
Urban RH
SPN 11%
Dorndorp [2] Multisite Oct 05 – RCT; 1.6-4.3y 5,425
Slide +/or
657 with
BC data
65 9.9% NR 60% children received antibiotics.
Mozambique Jul 10 Severe malaria. RDT + ve
Gambia Multi center
Kenya DRC
Ghana
Tanzania
Uganda
Nigeria
Rwanda
Enwere [39] Banjul,
Gambia
1992-1994 RCT; Cerebral
malaria
1-9y 576 276 with
BC data
14 5.1% S. aureus 42.9% Possible contaminants. High survival rate
without antibiotic treatment.
(BCS ≤2)
Urban TH
EGN 28.6%
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Table 1 Summary of 22 observational studies recording invasive bacterial infection (IBI) in children with Plasmodium falciparum malaria in sSA (Continued)
Evans [22] Kumasi,
Ghana
nr PCS; 4 m-11y 251 182 with
BC data
23 12.6% NTS 43% OR for IBI 3.5 (95% CI 1.4-8.2). No positive
association of SM and bacteremia.
Pub 2004 Severe malaria.
Urban TH
S.aureus 39%
E.coli 4%
Kremsner [42] Lambarene,
Gabon
nr PCS; sub-analysis
of Abx trial;
Severe malaria
>6 m 100 59 with 7 11.9% S. aureus
(3) 42.9%
Addition of clindamycin to quinine
shortened disease course
Pub 1995 Rural DH BC data EGN (2) 28.5%
Prada [43] Lagos,
Nigeria
May 92 – Aug 92 PCS; Cerebral
malaria
4 m-6y 50 50 8 16% All EGN 75% Hemolytic activity detected in 50% of
bacterial strains analyzed
Urban TH Salmonella 25%
ALL SEVERITY MALARIA
Akinyemi [44] Lagos,
Nigeria
Oct 04 – Sept 05 PCS; Febrile illness. 0-15ya 235 60 5 5/60 S. tyhpi 45.2% Only salmonella isolates reported. Included
adults Child results reported here
(unless indicated).S. enteritidis 24.2%
2 urban RHs &
2 urban clinics
(8.3%) (Incl adults)
Akpede [40] Benin,
Nigeria
Oct 88 – Oct 89 PCS; 1 m-5y 642 446 67 43/446 S. aureus 39.5% Reanalysis of data. Retracted original
suggestion of association of IBI and malaria.
Note case fraction of IBI in malaria inaccurate
(non-malarial febrile illness not differentiated)
Signs of febrile
illness
(9.6%) EGN 23.2%
Urban TH
Bahwere [25] Lwiro, DRC Jan 89 – Dec 90 RCS; NRa 779 182 124 45/182 All patientsb Positive malaria film and anemia (Hb < 8)
associated with higher IBI case fraction
All hospital
admissions.
Rural DH
(24.7%) NTS 36.5%,
E. coli 15.1%,
Citrobacter 6.3%
Berkley [52] Kilifi, Kenya Feb 99 – Dec 01 RCS; >60d 11,847 5,270 843 157/5,270
(3.0%)
NR Source data (Berkley 2009) [24]
All hospital
admissions.
Rural DH
1/9 with syndrome indicating Abx Rx had IBI.
Mabey [26] Fajara,
Gambia
Jan 79 – Oct 84 RCS; NR 5,466 426 146 43/426 NTS 69.8% Seasonal association of iNTS with malaria.
NTS rare (3%) in kids >4y. iNTS more
common in malaria season.All hospital
admissions.
Rural DH
incl recent
malaria
(10.1%) S. typhi 11.6%
Mtove [45] Muheza,
Tanzania
Mar 08 – Feb 09 PCS; 2 m-14y 1,502 947 156 75/947 All patientsb Invasive NTS more likely to have malaria,
recent malaria, anemia, low glucose
Febrile illness +
≥1 severity
criteria.
incl
RDT + ve
(7.9%) NTS 29%
E. coli 17%
Rural DH S. typhi 9%
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Table 1 Summary of 22 observational studies recording invasive bacterial infection (IBI) in children with Plasmodium falciparum malaria in sSA (Continued)
Nadjm [5] Muheza,
Tanzania
June 06 - May 07 PCS; 2 m-13y 3,639 2195 341 100/2,195
(4.6%)
NTS 52% >50% organisms not susceptible to 1st line
Abx. Case fatality non-malaria IBI = 19%
Fever in last 48 h.
Rural DH
Okwara [20] Nairobi,
Kenya
Jan 01 – Mar 01 CSS; 3 m-12y 264 158 32 18/158 Any GNR 62.5% Also examined urinary isolates. 60%
malaria dx in non-endemic area
Febrile Illness. (11.4%) NTS 34.4%
Urban TH
Sigauque [71] Manhica,
Mozambique
May 01- April 06 RCS; 0-15ya 23,686 10,699 1,550 621/10,699
(5.8%)
All patientsb Almost half of the community acquired
bacteremias had concomitant malaria
All hospital
admissions.
Rural DH
NTS 26%
SPN 25%
S. aureus 12%
E. coli 10%
Were [41] Siaya, Kenya Mar 04 – Jan 06 PCS; Malaria
admissions;
1 m-36 m 585 585 59 59/506 NTS 42.3% Proportion of IBI decreased with increasing
parasitemia. Excluded previous hospitalization
and CM.(11.7%) S. typhi 37%;
Rural DH S. aureus 35.6%
NON-SEVERE MALARIA
Ayoola [27] Ibadan,
Nigeria
Jun – Nov 98 PCS; 1 m-12 m 102 47 39 16/47 Gram pos 56% Excluded SM and if history of antibiotic use
in preceding 7 days
Fever. Urban TH (34%) Gram neg44%
Brent [28] Kilifi, Kenya May 03 – Oct 03 PCS; Unselected
outpatient
attendees.
0-5ya 1093 480 22 7/480 All patientsb Recruitment outside of malaria season.
Excluded children with recent admission
(10 days)
Rural DH (1.5%) SPN 50%
aStudy population may have included neonates - unable to extract information from the text; bmicrobial prevalences refer to all study patients (not only those with malaria and IBI). Abx, antibiotic; BC, blood culture;
CAB, community acquired bacteremia; CCS, cross sectional survey; DH, district hospital; MH, mission hospital; NR, not reported; PCS, prospective case series; RCS, retrospective case series; RCT, randomized controlled
trial; RDT, rapid (malaria) diagnostic test; RH, referral hospital; Rx, treatment; TH, teaching hospital. Organisms: EGN, enteric gram negatives; GN, gram negative organisms; GPO, gram positive organisms; HIb,
Haemophilus influenzae Group B; NTS, non-typhoidal salmonellae; Salm spp, salmonellae species; SPN, Streptococcus pneumoniae. Malaria definitions: IC, impaired consciousness; RD, respiratory distress; SMA, severe
malaria anemia.
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Table 2 Epidemiological studies reporting the incidence of malaria and IBI infection over time
EPIDEMIOLOGICAL STUDIES
Author Location Study period Study type; primary
inclusion criteria
Age Change in
incidence of
malaria BSI
Change in incidence
of IBI Per 100,000
person years
Case-fraction of
IBI co-infection
Predominant
organisms for
IBI co-infection
Comments
Mackenzie [32] Fajara and
Basse,
Gambia
1979 – 2008
Multiple
time points
Retrospective comparative
case series; 4 data sets: BC
taken from unwell children
or suspected IBI. Routine
malaria slides for febrile
children
Most <5y % Malaria in febrile
children
Fajara: 60 to 10
(1979 to 2005)
NR NR NTS declined in parallel with
malaria but pneumococcal
bacteremia did not.
Fajara: 33% to 6%
(1999 to 2007)
Basse: 105 to 29
(1989 to 2008)
Basse: 45% to 10%
(1992 to 2008)
Mtove [33] Muheza,
Tanzania
2006 – 2010 Cumulative data from three
prospective case series;
Severely ill febrile children
2 m-14y 547 to 106/100,000
person years
Overall from 167/1,898 (8.8%) All patientsa Severe malaria only. S. typhi
most common in older age
group (5-14y), and increased
with decreasing malaria.
184 to 60: NTS 34%
NTS: 82 to 7
SPN: 34 to 7
HIb: 21 to 4
S. typhi: 7 to 15
Scott [31] Kilifi, Kenya 1999 - 2009 Case control and longitudinal
study; Cases: hospital
admissions with bacteremia.
Controls: children born in
study area.
0-13y 28.5 to 3.45/1,000
person years
2.59 to 1.45/1000
person years
NR All patients in
matched case–
control studya
Reduction in protection
afforded by HbAS in parallel
(P = 0.0008). 62% bacteremia
cases attributable to malaria
All GNs 33.2%
SPN 38%
NTS 20.9%
amicrobial spectra refer to all study patients (not only those with malaria and IBI) } Abx, antibiotic; BC, blood culture; CAB, community acquired bacteremia; CCS, cross sectional survey; DH, district hospital; IBI, invasive
bacterial infections; HbAS, Sickle cell trait MH, mission hospital; NR, not reported; PCS, prospective case series; RCS, retrospective case series; RCT, randomized controlled trial; RDT, rapid (malaria) diagnostic test; RH,
referral hospital; Rx, treatment; TH, teaching hospital. Organisms: EGN, enteric gram negatives; GN, gram negative organisms; GPO, gram positive organisms; HIb, Haemophilus influenzae Group B; NTS, non-typhoidal
salmonellae; Salm spp, Salmonellae species; SPN, Streptococcus pneumoniae.
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Table 3 Quality assessment of studies describing children with severe malaria (SM) and concomitant invasive bacterial infection (IBI) with calculated case
fractions and case fatality rates
Study Study inclusion criteria for severe
malaria compared to WHO definitiona
N with
IBI data
% without
IBI data
Overall mortality rate n
IBI
Case fraction
(%) with IBI
Case fatality
malaria with
concomitant
IBI (%)
Case fatality
malaria
without
IBI (%)
Overall
rating
of study
quality
Ranking
severe malaria (%) co-infection
(95% CI)
Berkley [16] IC or RD + parasitemia (one slide)
Excludes SMA without IC or RD
643 18% 89/783 (11.4%) 42 6.53 (4.56-8.51) 14/42 (33%) 52/498 (10%) High YYY
Berkley [24] IC or RD or SMA + parasitemia
(any of three slides)
2,048 0.5% 76/861 (8.8%) 127 6.2 (5.12-7.73) 36/127 (28%) 137/1921 (7.1%) High YYY
Bronzan [38] WHO plus asexual parasitemia
(slide repeated six hrly). Clinical
signs do not include RD
1,388 5.3% 235/1,388 (16.9%) 64 4.61 (3.48-5.74) 14/64 (22%) 211/1324 (16%) High YYY
Evans [24] WHO definition plus asexual
parasitemia (one slide)
182 0% 16/182 (8.8%) 23 12.64 (7.47-17.8) 2/23 (8.7%) 14/159 (8.8%) High YYY
Subtotal 4,261 416/3,224 (12.9) 256 6.01 (5.27-6.74)
Bassat [23] WHO signs (incl glucose <2.2 mmol/L) +
asexual parasitemia (one thick film)
1,404 12% 81/1,648 (4.9%) 76 5.41 (4.2-6.63) 13/59 (22%) 50/1244 (4.0%) Moderate YYN
Dondorp [2] WHO definition plus RDT positive;
requiring parenteral treatment
657 NR (88%)
(BC data not
available in
all patients)
527/5,425 (9.7%) 65 9.89 (7.49-12.3) NR NR Moderate YNY
Enwere [39] Cerebral malaria (BCS < =2) plus
asexual parasitemia)
276 52% (BCx data
not consecutive)
122/576 (21.1%) 14 5.07 (2.42-7.73) 1/14 (7.1%) 121/562 (22%) Moderate YNY
Subtotal 2,337 155 6.63 (5.59-7.68)
Angyo [39] Clinical signs also include hypoglycemia;
shock; DIC; acidosis; hemoglobinuria. Did
not include confirmed parasitemia.
501 NR 16/501 (3.2%) 35 6.99 (4.67-9.30) NR NR Low YNN
Kremsner [42] Clinical signs also include hyperparasitemia,
glucose <2.2. Excludes children with Sickle
Cell disease.
59 41% (BCx data
not consecutive)
2/100 (2%) 7 11.86 (3.08-35.1) 1/7 (14%) 0/52 (0%) Low YNN
Prada [43] Cerebral malaria only (not defined) 50 NR 8 16.0 (4.91-27.09) NR NR Low NYN
Subtotal 610 50 8.2 (5.92-24.26)
Overall total 7,208 461 6.40 (5.81-6.98) 81/336 585/5760
(24.1%) (10.2%)
aWHO Definition = clinical symptoms suggestive of SM according to WHO guidelines which includes children with the following symptoms or signs: 1) a Blantyre coma score (BCS) of two or less; 2) severe anemia with
a hemoglobin level <5 g/dl or a hematocrit <15%; 3) severe respiratory distress, being marked in-drawing of the lower chest wall or deep (acidotic) breathing; and 4) prostration, being the inability to sit upright in a
child able to do so, or to drink in the case of children too young to sit. Ranking is based on: 1) criteria for SM clearly defined; 2) bacterial species defined and contaminants excluded; and 3) mortality rate >7.4%
(lowest CI in AQUAMAT) for SM cases. High = YYY, Moderate = YYN/YNY/NYY; Low = NNY/NYN/YNN for each of the criteria. BC, blood culture; NR, not reported; RDT, rapid (malaria) diagnostic test; Malaria definitions;
IC, impaired consciousness; RD, respiratory distress; SMA, severe malaria anemia.
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Table 4 Comparison of IBI in both malaria and non-malaria paediatric hospital admissions
Author Malaria Malaria/IBI Malaria case fraction
with IBI
Non-malarial
illness
Non-malarial
illness/IBI
Non-malaria case
fraction with IBI
Malaria attributable
fraction of IBI
Case fatality
malaria
Case fatality
malaria/IBI
number number number number
Akinyemi [44] 60 5 8.33% NR NR - -
Akpede [40] 446 43 9.64% 196 24 12.24% −2.60% 9/403 (2.2%) 3/43 (7.0%)
Bahwere [25] 182 45 24.73% 597 79 13.23% 11.49% NR NR
Berkley [52] 5,270 157 2.98% 6,516 677 10.39% −7.41% 110/1,143 (9.6%) 27/83 (32.5%)
Mabey [26] 426 43 10.09% 5,240 103 1.97% 8.13% NR NR
Mtove [45] 947 75 7.92% 555 81 14.59% −6.67% NR NR
Nadjm [5] 2,195 100 4.56% 1,444 241 16.69% −12.13% 76/2,051 (3.7%) 13/100 (13%)
Okwara [20] 158 18 11.39% 106 14 13.21% −1.82% NR NR
Sigauque [69] 10,699 621 3.15% 12,987 929 7.15% −4.00% NR NR
Were [41] 506 59 11.66% - - - - 2/447 (0.4%) 2/59 (3.4%)
Total 20,889 1,166 5.58% (95% CI 5.34-5.50) 27,641 2,148 7.77% (95% CI 7.72-7.83) −2.35%a 197/4,044 (4.9%) 45/285 (15.8%)
aCalculation of total case fraction excludes data from studies without non-malaria comparator group (that is, Akinyemi(43) and Were(40)). IBI, invasive bacterial infections.
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have coincident malaria and anemia than children infected
with other organisms [30].
Epidemiological studies
Three studies (see Table 2) describe and analyze data from
regions in sSA where a decline in malaria burden has been
paralleled by a fall in the incidence of IBI. A longitudinal
case–control study in Kenya, examining host protection
against bacteremia involving 1,454 cases (sickle cell trait)
and 10,749 controls [31] showed that at the beginning of the
study, when malaria transmission was meso-hyperendemic
(mean community parasite prevalence was 29%), the
bacteremia incidence rate ratio associated with malaria
parasitemia was 6.69 (95% CI 1.31 to 34.3)] in children
three-months- to thirteen-years-old. At this time, 62%
(8.2 to 91) of bacteremia cases occurred in children
with malaria infection, and sickle cell trait (HbAS) was
found to be strongly protective against hospital-admission
with bacteremia. Over the nine-year period, as the inci-
dence of admission to hospital with malaria per 1,000
child-years decreased from 28.5 to 3.45, a parallel reduc-
tion in protection afforded by HbAS against bacteremia
was observed. The largest reduction was in the inci-
dence of NTS bacteremia, which was mirrored by a
similar reduction in the protective effect of sickle cell
trait against this organism.
In separate sites in the Gambia (Fajara and Basse) at
three and four time points between 1979 and 2008, the
incidence of NTS infections in children was compared to
both the proportion of malaria-positive thick blood films
in outpatients and the percentage of malaria admissions
(Fajara only) [32]. NTS incidence declined in parallel with
a reduction in the incidence of malaria. While this obser-
vation may have resulted from an overall improvement in
health care in the study area, increased community use of
antimicrobials or methodological bias, a similar effect was
not demonstrated for invasive pneumococcal disease.
Similarly, in Tanzania a decline in malaria transmission
was also associated with declines in all-cause bacteremia,
largely driven by an 11-fold reduction in NTS [33]. How-
ever, the Phase III muticenter RTS,S vaccine trial, involv-
ing 15,460 children six-weeks- to seventeen-months-old
in seven African countries, showed that the RTS,S/AS01
achieved 35% effectiveness against severe malaria but did
not show an effect on all-cause bacteremia [34].
Mortality in malaria with concomitant IBI
In general, African children hospitalized with bacteremia
have a poor prognosis [35]. The outcome of children
co-infected with malaria and IBI also appears to be
worse than cases of SM alone. Six studies reported mor-
tality in children with SM with and without invasive
bacteremia (Table 3). Together there were 81 fatalities,24.1% (95% CI 18.86 to 29.36) in 336 children with
malaria/IBI co-infection compared to 585 deaths in
5,760 children with malaria infection alone, 10.2% deaths
(95% CI 9.33 to 10.98).
One prospective study of children admitted with clinical
features of SM included 182 film-positive children: 23 had
bacteremia (12.6%) and 2 of these died (8.7%) compared to
69 slide-negative children where 28 (41%) had bacteremia
and of these 11 died (39.2%). Overall, morality was greatest
in children younger than 18 months [22]. Other studies did
not report mortality data by age group.
A retrospective study including 783 Kenyan chil-
dren with SM showed a three-fold increase in mortality
(10.4% to 33.3%) in those with IBI compared to those
without IBI (P <0.001) [36]. A similar threefold increase
in mortality was shown in Tanzanian children with
malaria and concomitant gram-negative bacteremia
[37]. The association between gram-negative organisms
(especially NTS bacteremia) and mortality was reinforced by
similar findings in Kenyan children [24]. In Mozambique,
mortality in children with malaria and IBI co-infection
increased from 4% to 22% (P <0.0001) [23]. Conversely,
studies reported from Malawi and The Gambia found
no relationship between malaria/IBI co-infection and
increased mortality [38,39].
Only four of the ten studies reporting case series of
febrile children with all severity malaria included data
on case fatality rates for both malaria and malaria/IBI
groups [5,35,40,41] (see Table 4). As with SM, case fa-
tality was again higher in those co-infected with IBI.
Overall, there were 45 deaths in 285 children with malaria/
IBI (15.8%) compared to 197 deaths in 4,044 children
with malaria alone (all forms) (4.9%). One study re-
ported no association between IBI and all severity mal-
aria [40]; however, 43% of all bacterial isolates in this
study (including children with non malaria fevers) were
due to Staphyloccocus aureus, compared to only 3% due
to Streptococcus pneumoniae and, thus, may be not rep-
resentative due to the possibility of contamination. Were
et al. [41] reported a six-fold higher case fatality rate in
malaria/IBI co-infection compared to malaria alone;
however, since case fatalities were few, in total only 4 in
585 (0.7%) cases of severe malaria, this association was
not significant. The study in Muheza, northeast Tanzania,
describes 3,639 children admitted to a district hospital with
febrile illness, where IBI increased mortality irrespective of
the presence of parasitemia [5].
Microbiological spectrum of IBI
Overall, 16 of the 22 studies in Table 1 report the preva-
lence and spectrum of pathogenic bacteria in children
with malaria infection. Taken together for children with
severe malaria five of eight studies found overall that the
prevalence of Gram positive organisms exceeded that of
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was the major pathogen isolated [39,40,42] and in two
studies >35% of isolates were S. aureus [22,41]. Overall,
seven of fourteen hospital-based studies reporting specific
microbiological data listed NTS as the most commonly
cultured organism in children with malaria, with the large
majority being Enteritidis and Typhimurium serovars
[5,20,22,26,38,41,43]. This increased to eight studies if
all EGNOs were considered [23]. Salmonellae Typhi
was reported in isolated cases, predominantly in older
children [26,44,45], with the majority of studies reporting
no occurrence of S. typhi.
Comparing the proportion of NTS in malaria versus
non-malaria infection we found that two of three SM
studies with a comparator non-malaria cohort recorded
a higher proportion of NTS bacteremia in the malaria
group [23,24]. Of the studies reporting all malaria cases,
two of three studies showed higher proportions of EGNOs
in malaria compared to non-malaria infections [5,26] but
NTS case numbers were only reported in one study [26].
NTS was strongly associated with recent malaria [5], which
has been reported in other cohorts [46].
Among Gram-positive organisms, S. pneumoniae is the
most common cause of IBI in children in Africa [4]. How-
ever, consensus appears to be lacking in the studies we
reviewed since some studies indicate frequent co-infection
with malaria [13,23,36,47] but others do not [5,22,24]. A
higher prevalence of HIV and the low frequencies of sickle
cell carriage in certain populations may explain these re-
gional differences [23]. In eight studies, S. aureus featured
as a common culture isolate in children with malaria,
exceeding 35% of all isolates in five of these studies;
however, there were no suggestions of a focus of infection
and contamination remains a possibility.
One study has reported the case fatality of malaria
complicated by Gram-positive bacteremia to be sub-
stantially lower than mortality in malaria complicated
by Gram-negative bacteremia (17.2% versus 45.7%,
respectively) [37]. Case fatality of the children with NTS
and EGNO bacteremia appeared to be greater than
other commonly isolated invasive bacterial pathogens
(range 0 to 47%); however, only one study [22] made
the comparison of NTS case fatality in malaria versus
non-malaria groups.
Clinical manifestations associated with malaria and
concomitant IBI
A number of in-hospital studies have examined clinical
manifestations associated with IBI co-morbidity, including
age, SM clinical phenotype, malaria endemicity, hyper-
parasitemia, and underlying illness [5,22-25,38,41,43,46].
Tanzanian infants (<20 months) had higher rates of IBI
co-infection (12%), particularly those <6 months old
(18.5%), compared to older age groups (7.8%) [36]. Asimilar prevalence (15.7%) has been reported in Nigerian
infants (>1- to 12-months-old) with malaria, with E. coli
being the most common organism (36% of all organisms)
[27]. IBI co-infection is also more commonly reported in
areas of high malaria transmission. In an area of low
transmission intensity, such as the island of Zanzibar, the
incidence of concomitant IBI appears to be low (0.4%) and
none had NTS [47]. The evidence surrounding hyperpara-
sitemia as a co-factor for IBI susceptibility is inconclusive.
Among children with SM and IBI in Kilifi, Kenya, 74% had
hyperparasitemia (>10,000 uL) [36]. In Muheza, Tanzania, a
third of children with malaria and IBI co-infection had high
parasite densities [5]. In Western Kenya and Mozambique
however, children with malaria and IBI (with EGNOs)
were significantly more likely to have lower parasite
densities [23,41].
The clinical phenotype of SM appears to be an im-
portant factor. Nigerian and Gambian children [39,43]
with cerebral malaria rarely had bacterial co-infection.
In Kenyan children, no association was found between the
prevalence of IBI and depth of coma score [36]; whereas
there was a higher case fraction with IBI in children pre-
senting with deep breathing (a putative clinical marker
of metabolic acidosis) [36]. Three studies reported that
severe malarial anemia (SMA) phenotype [23,38,41] had a
higher case fraction with IBI than other clinical manifesta-
tions of SM, which was also reported in studies involving
all malaria [5,25,26] and this association was largely due to
NTS co-infection [26,46,48]. In Malawi, compared to chil-
dren with cerebral malaria (3.0%), those with SMA had a
higher prevalence of IBI co-infection (11.7%), largely NTS
bacteremia [38]. Of note are independent studies of NTS,
conducted at the same hospital in Malawi and in Muheza,
Tanzania, which described a positive association with
both acute or recent malaria infection and anemia [45,48].
Similarly, in Kenyan children, three quarters of patients
with NTS bacteremia complicated by anemia had evidence
of a recent or current malaria infection [46].
While there is enormous epidemiological potential for
co-occurrence of malaria infection, malnutrition and HIV
in much of sSA, the limited data available do not support
such an association. Concomitant IBI was more common
in underweight children (Z-score < −2) [41] and higher
parasite densities were noted in Kenyan children who
were HIV positive [24]. Other studies, possibly due to
limited sample size were unable to demonstrate a signifi-
cant association between malaria complicated by IBI and
malnutrition or HIV [37,38]. One possible explanation
for a lack of association is that immunocompromised
HIV-infected children may be protected from infection
by the combined antimicrobial and antiparasitic proper-
ties of prophylactic co-trimoxazole [49].
Simple clinical criteria proposed by Nadjm et al. [5]
identified 85% of malaria cases with culture-proven
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current axillary temperature >38°C or <36°C, a positive
rapid diagnostic test (RDT) or blood film for malaria,
and one or more of: prostration; respiratory distress; severe
anemia (hemoglobin <5 g/dL), or HIV infection.
Discussion
Collated data examining the potential biological relation-
ship between malaria and invasive bacterial infection
across a range of studies conducted in sSA is by no
means conclusive. For SM the case fraction of children
with IBI co-infection was 6.4% (95% CI 5.81 to 6.98%) but
with substantial between-study variability, mostly due to
differences in study methodology including the case def-
inition of SM. In prospective studies of febrile children
admitted to health facilities with all-severity malaria, the
case fraction with IBI was lower in children with malaria
(5.6%) compared to non-malaria febrile illness (7.8%). For
children with all-severity malaria (including recent infection)
NTS was more commonly isolated than in non-malarial
febrile illness. Added to this, several large studies [5,24]
provide further support that EGNO (including NTS species)
bacterial isolates are more common in children with malaria
compared to non-malaria illness, but this finding was
not universal. In children with SM neither those with
cerebral malaria nor children with neurological complica-
tions appeared at increased risk of IBI; however, a higher
proportion of children with SMA had IBI, principally NTS.
Children with malaria and IBI infection had a substantially
higher mortality (22%), compared to those without (12%).
However, the most compelling data on the predisposition
of malaria-exposed children to IBI comes from longitudinal
studies capturing declining risk of IBI, spectrum of IBI
organisms and risk of mortality in parallel to an epidemio-
logical transition from high to low malaria endemicity. The
largest reduction was in the incidence of NTS bacteremia,
which was mirrored by a similar reduction in the protective
effect of sickle cell trait against this organism. The data
we have collated from hospital cohort studies corre-
sponds with the findings reported in epidemiological
studies but is less conclusive.
Teasing apart the association between malaria and IBI
has been challenging for several reasons. Foremost, both
malarial parasitemia and IBI are common in children
presenting with fever in malaria endemic areas. Rainy
seasons in the tropics predispose to blood borne infection
with enteric pathogens as well as malaria outbreaks [50,51].
Hospitalized children often have overlapping etiological
syndromes [52], for example, 27% of Mozambican chil-
dren with radiologically confirmed pneumonias also had
confirmed asexual parasitemia [30]. The limitations im-
posed by the lack of routine high quality microbiology
services in sSA have resulted in a fragmented and patchy
understanding of this association and its importance. Hardto culture pathogens, such as NTS [53], may be under-
reported, conversely contamination remains a possibility
in those studies reporting high incidences of staphylococ-
cal organisms [27,39,40,42] and requires substantiating by
further studies.
The findings of this review are subject to methodological
limitations. Heterogeneity was high between studies. Only a
few papers recorded sufficient data to allow standardization
of populations. Inclusion of recent malaria infection, using
antigen-based rapid diagnostic tests, has shed more light
on the prevalence of co-infection and needs further inves-
tigation. We were also unable to control for differences in
study design and quality of microbiological data. For many
studies, the prevalence of IBI co-infecting malaria was not
the primary question, making a formal meta-analysis po-
tentially misleading. Unpublished data were not included
and, therefore, our findings may have a publication bias
towards studies that report high level of concordance. In
children with SM the strength of a biological association
with IBI is even more difficult to establish due to the pau-
city of data from an appropriate control population with
severe life threatening illness. Our findings do, however,
concur with the conclusions of the systematic review and
meta-analysis of community acquired bacterial infection
indicating co-infection in 6.5% of children with malaria
(any type) [4].
A putative clinical association between malaria and IBI
was first suggested in the 1920s in Guyana by Giglioli
who observed both increased prevalence and virulence
of paratyphoid fever during malaria seasons with a co-
infection rate of 29% [54]. A similar rise in typhoid
fever in Nigerian children during the rainy season was
speculated to be linked to the increased incidence of
malaria [55]. These observations of seasonal concurrence
of NTS infection and malaria were further explored in
Gambian children [26] showing that while stool carriage
of NTS remained constant throughout the year, rises in
invasive NTS infections occurred in parallel to the annual
rise in malaria cases.
The propensity for co-infection with EGNOs has led
to speculation that the source of the microorganisms is
most likely to be from the intestine due to impaired
gut barrier function [56]. A recent mouse experiment
may help our understanding of the reasons why children
with malaria maybe more susceptible to concomitant
NTS at the biological level [57]. The production of
hemoxygenase (HO-1), which is induced in response
to malaria hemolysis, resulted in impaired defense by
mice towards NTS infection. While not yet replicated
in humans the underlying mechanisms and portal of
entry of pathogens into the bloodstream include either,
or a combination of, mechanical and immune-suppressive
factors. Histopathological studies have demonstrated in-
tense sequestration of P. falciparum-infected erythrocytes
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tip of intestinal villi [58,59]. The presence of small bowel
intussusceptions in children with SM [60] has also been
reported. The intense sequestration of late stage infected
erythrocytes in venules and capillaries as well as the in-
creased rigidity (or non-deformability) of non-parasitized
red cells [61] both compromise microcirculatory flow to
vital organs and alter endothelial cell function [62]. This
may precipitate injury and impaired gut barrier function
either directly or indirectly through local cytokine pro-
duction, with the subsequent transfer of endotoxin and/
or pathogenic bacteria into the blood stream. We have
recently shown that endotoxemia is common in SM (28%)
and results in temporary immune paralysis similar to that
observed in patients with sepsis and experimentally-
induced endotoxemia [63]. We hypothesized that the
most likely origin of endotoxin was from the gut.
Although current recommendations for managing pu-
tative sepsis in children with SM are unclear [46,64], the
ideal approach is not obvious [65,66]. For example, in
one recent study almost 50% of bacterial isolates were
resistant to the antibiotics most commonly recommended
for empirical use by the WHO [5]. Moreover, in the spe-
cific case of NTS, the efficacy of gentamicin is doubtful
and susceptibility testing unreliable due to the intracellular
nature of this infection [67,68]. For newer antimicrobials,
apart from financial considerations, there are concerns
that over-use could lead to resistance. Judicious use of
antibiotics may prove to be critical to those at highest
risk of poor outcome.Conclusions
Establishing the relationship, both proof and effect, between
malaria and IBI has been challenging. The accumulated
evidence suggests that children with recent or acute mal-
aria are at risk of bacterial infection, which results in an
increased risk of mortality. Establishing which children
with SM are at greatest risk of bacteremia would inform a
policy for targeted antibiotic therapy that could substan-
tially reduce malaria-associated mortality while minim-
izing the risks of excess antibiotic prescribing.Additional file
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Excluded studies referring to malaria and invasive bacterial infection.
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